Internal Medicine, Critical Care Medicine · Philadelphia, PA
NPI
1851323851
Since 2006
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3400 Spruce Street
Philadelphia, PA, 19104
Phone (215) 662-3202
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
383 services
Medicare patients, 2024
176
Average age 76
Drug cost, 2024
$914K
764 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory Tino was code 99214 (office e&m - established), 177 times for 109 patients. In total Gregory Tino billed 383 services in 10 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 177 | 109 | $72.98 | $13K |
| 99215 Office E&M - Established | Facility | 98 | 58 | $109.87 | $11K |
| 99213 Office E&M - Established | Facility | 26 | 23 | $49.20 | $1,279 |
| 99205 Office E&M - New | Facility | 14 | 14 | $147.20 | $2,061 |
By year: 2022 $35K for 382 services; 2023 $36K for 383 services; 2024 $34K for 383 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gregory Tino prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 92 prescriptions and refills. In total Gregory Tino wrote 764 Medicare prescriptions that cost $914K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 92 | 200 | 24 | $123K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 90 | 142 | 18 | $62K |
| Prednisone Generic | 67 | 102 | 25 | $274 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 61 | 99 | 30 | $2,577 |
| Breo Ellipta Fluticasone/Vilanterol | 48 | 60 | Under 11 | $22K |
| Incruse Ellipta Umeclidinium Bromide | 47 | 69 | Under 11 | $22K |
| Ofev Nintedanib Esylate | 38 | 38 | Under 11 | $510K |
| Colistimethate Colistin (Colistimethate Na) | 25 | 28 | Under 11 | $21K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 20 | 20 | 15 | $108 |
| Omeprazole Generic | 20 | 32 | Under 11 | $152 |
| Famotidine Generic | 19 | 25 | Under 11 | $193 |
| Azithromycin Generic | 18 | 42 | Under 11 | $567 |
| Levofloxacin Generic | 18 | 18 | 12 | $210 |
| Esomeprazole Magnesium Generic | 16 | 26 | Under 11 | $529 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 16 | 31 | Under 11 | $99.29 |
Brand drugs: 444 claims; generic drugs: - claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Gregory Tino were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.